Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.530
+0.1653.08%
Volume:625.85K
Turnover:3.47M
Market Cap:4.51B
PE:-23.65
High:5.800
Open:5.395
Low:5.335
Close:5.365
52wk High:10.860
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:3.42
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.234
ROE:-3.45%
ROA:-1.93%
PB:1.06
PE(LYR):-23.65
PS:4.13

Loading ...

Ascletis Pharma Surges on US Obesity Drug Trial Launch

Deep News
·
5 hours ago

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Yesterday

HK Stock Market Alert | VIVA BIOTECH (01873) Surges Over 5% as Two New CDMO Commercial Projects from Langhua Pharma Drive Key Revenue Growth

Stock News
·
Yesterday

The AI Drug Discovery Sector Enters Its Value-Realization Phase, Unlocking Fresh Growth Avenues for Innovative Medicines

Deep News
·
Sep 08

Ionis Pharmaceuticals Shares Slide 13.1% in Pre-Market Trading

Deep News
·
Sep 08

ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis

Stock News
·
Sep 08

Nanxin Pharmaceutical Receives Penalty for Disclosure Violations, Affected Investors May Seek Compensation

Deep News
·
Sep 08

HK Market Alert: Biocytogen-B (02315) Surges Over 10% in Afternoon Trade Following Exclusive Licensing Agreement with Qilu Pharmaceutical

Stock News
·
Sep 08

Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D

Stock News
·
Sep 08

Riding on One-Off Licensing Income, Suzhou Zelgen's Hong Kong Listing Ambitions Face Scrutiny Amid First Post-IPO Semi-Annual Profit

Stock News
·
Sep 07

Hong Kong Stock Market Flash | METIS TECHBIO-P (07666) Surges Over 15% in Morning Session, Leading the AI Drug Development Sector as AI4S Commercialization Picks Up Pace

Stock News
·
Sep 07

Suzhou Zelgen's New Thyroid Cancer Treatment Application Accepted by Regulators

Stock News
·
Sep 06

Critical Safety Flaws in Huatai Pharmaceutical's Emergency Drug Lead to Exclusion from National Procurement Program

Deep News
·
Sep 05

AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO

Deep News
·
Sep 05

Ocumension Posts Stable Share Capital Structure for August 2026; Confirms Public-Float Compliance

Bulletin Express
·
Sep 04

OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment

Stock News
·
Sep 02

Ocumension Completes Enrollment in China Phase III Trial of Dry Eye Drug OT-211

Reuters
·
Sep 02

歌礼制药-B股价早盘攀升逾8%,重磅减肥药全球III期试验迎来关键里程碑

Deep News
·
Sep 02

Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted by NMPA

Reuters
·
Sep 02

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Stock News
·
Sep 01